TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Navitor TAVR valve in the Abbott booth at TCT 2023. Photo by Dave Fornell

Self-expanding TAVR system with new sealing cuff linked to high success rate, favorable outcomes

The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023. 

January 8, 2024
Stroke - head with text

TAVR patients face a higher risk of stroke for up to 2 years

A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer. 

January 4, 2024
surgery.jpg

Endocarditis after SAVR more likely with bovine valves

Researchers examined data from more than 21,000 patients treated from 1997 to 2018, publishing their findings in the Journal of the American Heart Association.

January 3, 2024
Damaged Organ

Acute kidney injury after TAVR linked to certain risks, but most patients have a full recovery

“These findings are highly pertinent in a clinical setting," researchers explained. 

January 2, 2024

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 

December 19, 2023
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.

AFib before and after TAVR linked to significant risks

The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure. 

December 13, 2023
sonographer echo

Good to great: 5 ways to help sonographers deliver better echocardiograms and improve the diagnosis of severe AS

Sponsored by Medtronic

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 

December 12, 2023
Medtronic Evolut FX TAVR valve

‘A huge victory for patient care’: Next-gen TAVR valve helps cardiologists target more patients

Sponsored by Medtronic

“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”

December 12, 2023